William J. Plovanic, Chief Financial Officer at OBALON THERAPEUTICS INC (OBLN), bought 30,000 shares at $4.05 ($121K) on 2018-03-13, disclosed to the SEC on 2018-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.05 | 9,588 | $39K | 32.0% |
| 2 | $4.05 | 9,700 | $39K | 32.4% |
| 3 | $4.04 | 5,300 | $21K | 17.6% |
| 4 | $4.04 | 5,412 | $22K | 18.0% |
| Total | $4.05 avg | 30,000 | $121K | 100% |
| Filing → |